These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8068411)

  • 1. Virus-specific helper T cell response of macaques immunized with inactivated whole SIV is not correlated with reactivity against cellular components of vaccine preparation.
    Dittmer U; Lüke W; Stahl-Hennig C; Hunsmann G; Voss G
    AIDS Res Hum Retroviruses; 1994 Apr; 10(4):329-30. PubMed ID: 8068411
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphoproliferative responses in macaques immunized with inactivated SIV vaccine.
    Teng XC; Ashworth LA; Sharpe SA; Dennis MJ; Cranage MP
    AIDS Res Hum Retroviruses; 1993 Aug; 9(8):799-801. PubMed ID: 8217348
    [No Abstract]   [Full Text] [Related]  

  • 3. Inactivated whole SIV vaccine in macaques: evaluation of protective efficacy against challenge with cell-free virus or infected cells.
    Johnson PR; Montefiori DC; Goldstein S; Hamm TE; Zhou J; Kitov S; Haigwood NL; Misher L; London WT; Gerin JL
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1501-5. PubMed ID: 1466990
    [No Abstract]   [Full Text] [Related]  

  • 4. Early helper T-cell dysfunction in simian immunodeficiency virus but not in human immunodeficiency virus type-2-infected macaques.
    Dittmer U; Lüke W; Stahl-Hennig C; Coulibaly C; Petry H; Bodemer W; Hunsmann G; Voss G
    J Med Primatol; 1994 Jul; 23(5):298-303. PubMed ID: 7869358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the B and T cell immune response to the envelope glycoprotein 130 (gp130) of the macaque strain of simian immunodeficiency virus (SIVmac), induced by immunization of rhesus macaques with virus-derived or vaccinia virus-expressed gp130.
    Voss G; Dittmer U; Coulibaly C; Makoschey B; Petry H; Lüke W; Hunsmann G
    J Gen Virol; 1993 Sep; 74 ( Pt 9)():1757-63. PubMed ID: 8376957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: potential role in vaccine efficacy.
    Leno M; Carter L; Venzon DJ; Romano J; Markham PD; Limbach K; Tartaglia J; Paoletti E; Benson J; Franchini G; Robert-Guroff M
    AIDS Res Hum Retroviruses; 1999 Mar; 15(5):461-70. PubMed ID: 10195756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of helper T-cells generated from macaques infected with attenuated simian immunodeficiency virus.
    Dittmer U; Feldmann G; Sauermann U; Spirng M; Uberla K; Stahl-Hennig C; Hunsmann G
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1801-7. PubMed ID: 9680145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine protection of rhesus macaques against simian immunodeficiency virus infection.
    Carlson JR; McGraw TP; Keddie E; Yee JL; Rosenthal A; Langlois AJ; Dickover R; Donovan R; Luciw PA; Jennings MB
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1239-46. PubMed ID: 2078406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immune response of macaques immunized with low doses of simian immunodeficiency virus (SIV).
    Dittmer U; Spring M; Petry H; Nisslein T; Rieckmann P; Lüke W; Stahl-Hennig C; Hunsmann G; Bodemer W
    J Biotechnol; 1996 Jan; 44(1-3):105-10. PubMed ID: 8717393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A formalin-fixed whole SIV vaccine induces protective responses that are cross-protective and durable.
    Murphey-Corb M; Ohkawa S; Davison-Fairburn B; Martin LN; Baskin GB; Langlois AJ; McIntee M; Narayan O; Gardner MB
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1475-8. PubMed ID: 1466986
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus.
    Cranage MP; Polyanskaya N; McBride B; Cook N; Ashworth LA; Dennis M; Baskerville A; Greenaway PJ; Corcoran T; Kitchin P
    AIDS Res Hum Retroviruses; 1993 Jan; 9(1):13-22. PubMed ID: 8427714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive immunization of rhesus macaques against SIV infection and disease.
    Gardner M; Rosenthal A; Jennings M; Yee J; Antipa L; Robinson E
    AIDS Res Hum Retroviruses; 1995 Jul; 11(7):843-54. PubMed ID: 7546912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus.
    Spear GT; Takefman DM; Sullivan BL; Landay AL; Jennings MB; Carlson JR
    Virology; 1993 Aug; 195(2):475-80. PubMed ID: 8337824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of anti-human cell antibodies in sera from macaques immunized with whole inactivated virus.
    Langlois AJ; Weinhold KJ; Matthews TJ; Greenberg ML; Bolognesi DP
    AIDS Res Hum Retroviruses; 1992 Sep; 8(9):1641-52. PubMed ID: 1457210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against SIV infection in macaques by immunization with inactivated virus from the BK28 molecular clone, but not with BK28-derived recombinant env and gag proteins.
    Mills KH; Page M; Chan WL; Kitchin P; Stott EJ; Taffs F; Jones W; Rose J; Ling C; Silvera P
    J Med Primatol; 1992; 21(2-3):50-8. PubMed ID: 1433267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine-induced CD4+ T cells against the simian immunodeficiency virus gag protein. Epitope specificity and relevance to protective immunity.
    Mills KH; Barnard AL; Williams M; Page M; Ling C; Stott EJ; Silvera P; Taffs F; Kingsman AS; Adams SE
    J Immunol; 1991 Nov; 147(10):3560-7. PubMed ID: 1719081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization of rhesus monkeys with high- and low-dose Tween-ether-disrupted SIVMAC.
    Voss G; Stahl-Hennig C; Petry H; Coulibaly C; Nick S; Fuchs D; Wachter H; Lüke W; Hunsmann G
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1397-400. PubMed ID: 1466966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of protection afforded by whole virus ISCOM versus MDP adjuvanted formalin-inactivated SIV vaccines from IV cell-free or cell-associated homologous challenge.
    Osterhaus A; de Vries P; Morein B; Akerblom L; Heeney J
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1507-10. PubMed ID: 1466991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine studies with the 32H reisolate of SIVmac251: an overview.
    Cranage M; Stott J; Mills K; Ashworth T; Taffs F; Farrar G; Chan L; Dennis M; Putkonen P; Biberfeld G
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1479-81. PubMed ID: 1466987
    [No Abstract]   [Full Text] [Related]  

  • 20. A formalin-inactivated whole SIV vaccine confers protection in macaques.
    Murphey-Corb M; Martin LN; Davison-Fairburn B; Montelaro RC; Miller M; West M; Ohkawa S; Baskin GB; Zhang JY; Putney SD
    Science; 1989 Dec; 246(4935):1293-7. PubMed ID: 2555923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.